V. Nüßler

440 total citations
23 papers, 336 citations indexed

About

V. Nüßler is a scholar working on Oncology, Molecular Biology and Hematology. According to data from OpenAlex, V. Nüßler has authored 23 papers receiving a total of 336 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Oncology, 9 papers in Molecular Biology and 6 papers in Hematology. Recurrent topics in V. Nüßler's work include Acute Myeloid Leukemia Research (4 papers), Drug Transport and Resistance Mechanisms (4 papers) and Retinoids in leukemia and cellular processes (4 papers). V. Nüßler is often cited by papers focused on Acute Myeloid Leukemia Research (4 papers), Drug Transport and Resistance Mechanisms (4 papers) and Retinoids in leukemia and cellular processes (4 papers). V. Nüßler collaborates with scholars based in Germany, Austria and Sweden. V. Nüßler's co-authors include R. Pelka‐Fleischer, W. Wilmanns, Frank Gieseler, Oliver J. Stoetzer, H. Zwierzina, Harald Biersack, Christopher McCabe, Karl‐Josef Kallen, Helmut R. Salih and A Wilisch and has published in prestigious journals such as Cancer, Annals of Oncology and European Journal of Cancer.

In The Last Decade

V. Nüßler

19 papers receiving 321 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
V. Nüßler Germany	10	146	119	68	52	51	23	336
Jennifer Rauw Canada	8	232 1.6×	123 1.0×	34 0.5×	39 0.8×	48 0.9×	14	398
Isabelle Soerjomataram France	5	108 0.7×	117 1.0×	45 0.7×	69 1.3×	30 0.6×	7	386
Andrew Dunford United States	6	183 1.3×	115 1.0×	24 0.4×	46 0.9×	52 1.0×	17	424
Emanuela Campalani United Kingdom	8	165 1.1×	78 0.7×	53 0.8×	91 1.8×	374 7.3×	14	593
Claire McGeown United Kingdom	7	119 0.8×	68 0.6×	31 0.5×	22 0.4×	254 5.0×	8	621
Mary Alma Welch United States	8	94 0.6×	104 0.9×	182 2.7×	79 1.5×	30 0.6×	18	329
Mohamed Belhocine France	10	497 3.4×	83 0.7×	109 1.6×	160 3.1×	111 2.2×	18	818
Elizabeth Jordan United States	11	220 1.5×	95 0.8×	63 0.9×	22 0.4×	38 0.7×	23	522
Mohcine Bennani Mechita Morocco	13	109 0.7×	60 0.5×	87 1.3×	21 0.4×	36 0.7×	36	381
Mardiah Suci Hardianti Indonesia	10	88 0.6×	99 0.8×	18 0.3×	21 0.4×	48 0.9×	55	315

Countries citing papers authored by V. Nüßler

Since Specialization

Citations

This map shows the geographic impact of V. Nüßler's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by V. Nüßler with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites V. Nüßler more than expected).

Fields of papers citing papers by V. Nüßler

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by V. Nüßler. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by V. Nüßler. The network helps show where V. Nüßler may publish in the future.

Co-authorship network of co-authors of V. Nüßler

This figure shows the co-authorship network connecting the top 25 collaborators of V. Nüßler. A scholar is included among the top collaborators of V. Nüßler based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with V. Nüßler. V. Nüßler is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Bergwelt‐Baildon, Michael von, et al.. (2022). 9th Immunotherapy of Cancer conference (ITOC): A meeting report. Human Vaccines & Immunotherapeutics. 18(7). 2159706–2159706. 2 indexed citations

Nüßler, V., et al.. (2019). Cancer Prevention with Nutrition and Lifestyle. Visceral Medicine. 35(4). 204–209. 38 indexed citations

Nüßler, V., et al.. (2018). Kachexie bei Tumorerkrankungen. Schmerzmedizin. 34(5). 45–45.

Schubert-Fritschle, G., Stephanie E. Combs, Thomas Kirchner, V. Nüßler, & Jutta Engel. (2017). Use of Multicenter Data in a Large Cancer Registry for Evaluation of Outcome and Implementation of Novel Concepts. Frontiers in Oncology. 7. 234–234. 5 indexed citations

McCabe, Christopher, Lothar Bergmann, Nicholas Bosanquet, et al.. (2008). Market and patient access to new oncology products in Europe: a current, multidisciplinary perspective. Annals of Oncology. 20(3). 403–412. 52 indexed citations

Zimmermann, Frank, et al.. (2007). Diagnostik und Therapie des Analkarzinoms. coloproctology. 29(1). 23–36.

Salih, Helmut R., Peter A. Kiener, & V. Nüßler. (2002). 4-1BB ligand – just another costimulating molecule?. International Journal of Clinical Pharmacology and Therapeutics. 40(8). 348–353. 10 indexed citations

Pelka‐Fleischer, R., et al.. (1999). Drug-induced apoptosis in chronic lymphocytic leukemia. Leukemia. 13(11). 1873–1880. 33 indexed citations

Gieseler, Frank & V. Nüßler. (1998). Cellular resistance mechanisms with impact on the therapy of multiple myeloma. Leukemia. 12(7). 1009–1012. 12 indexed citations

10.

Gieseler, Frank, et al.. (1998). Intracellular pharmacokinetics of anthracyclines in human leukemia cells: correlation of DNA-binding with apoptotic cell death.. PubMed. 36(1). 25–8. 16 indexed citations

11.

Nüßler, V., Frank Gieseler, H. Zwierzina, et al.. (1997). Idarubicin monotherapy in multiply pretreated leukemia patients: response in relation to P-glycoprotein expression. Annals of Hematology. 74(2). 57–64. 9 indexed citations

12.

Radulescu, Razvan T., Hongyu Liu, Baoyan Zhang, W. Wilmanns, & V. Nüßler. (1997). Retinoblastoma protein-derived peptides: Further definition of their antineoplastic properties. European Journal of Cancer. 33. S35–S35. 2 indexed citations

13.

Radulescu, Razvan T., W. Wilmanns, & V. Nüßler. (1997). Leucine zipper, nuclear targeting and P130 interaction motifs in the epidermal growth factor precursor: The nucleocrine connection further unveiled. European Journal of Cancer. 33. S15–S15. 2 indexed citations

14.

Zwierzina, H., T. Bammer, Manfred Herold, et al.. (1996). In vitro stimulation of erythropoiesis by stem cell factor alone in myelodysplastic syndrome patients with elevated endogenous erythropoietin serum levels.. PubMed. 2(6). 1031–8. 2 indexed citations

15.

Stoetzer, Oliver J., et al.. (1996). Association of bcl-2, bax, bcl-xL and interleukin-1 beta-converting enzyme expression with initial response to chemotherapy in acute myeloid leukemia.. PubMed. 10 Suppl 3. S18–S22. 75 indexed citations

16.

Fateh-Moghadam, A., et al.. (1994). Serum β2-Microglobulin for Staging and Monitoring of Multiple Myelomas and Other Non-Hodgkin Lymphomas. Oncology Research and Treatment. 17(4). 428–432. 2 indexed citations

17.

Gieseler, Frank, et al.. (1994). Cytotoxicity of anthracyclines: Correlation with cellular uptake, intracellular distribution and DNA binding. Annals of Hematology. 69(1). S13–S17. 24 indexed citations

18.

Nüßler, V., R. Pelka‐Fleischer, H. Zwierzina, et al.. (1994). Clinical importance of P-glycoprotein-related resistance in leukemia and myelodysplastic syndromes — first experience with their reversal. Annals of Hematology. 69(1). S25–S29. 17 indexed citations

19.

Wilisch, A, Rupert Handgretinger, Stefan Weger, et al.. (1993). Mdr1P-glycoprotein expression in natural killer (NK) cells enriched from peripheral or umbilical cord blood. Cancer Letters. 69(2). 139–148. 22 indexed citations

20.

Nüßler, V., H. Sauer, R. Pelka‐Fleischer, D. Hölzel, & W. Wilmanns. (1990). Clinical, biochemical and cytokinetic parameters for distinguishing smouldering and rapidly proliferating variants of acute leukaemia. European Journal Of Haematology. 45(1). 19–25. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact